Cromos Pharma's CEO Dr. Vlad Bogin has published an article in the leading Russian Pharma periodical "Pharmvestnik". The article discusses the possible reasons for discrepancies in the results of the TOPCAT trial.

Please follow the link to the article that provides the detailed insight into this issue.